Meddiction specializes in developing addiction diagnosis and treatment solutions based on integrating the latest innovations in IT and healthcare technology.
In collaboration with Harvard Medical School, Meddiction has commercialized the world 's first alcoholism treatment system using virtual reality. Currently, 8 medical centers including the Korean National Mental Hospital, Chung Ang University Hospital and Gangnam Eulji Hospital use Meddiction products.
Additionally, we have developed a revolutionary diagnosis solution that objectively quantifies the degree of addiction in patients by using complex bio-signal analyses (ECG, EEG, HRV etc), improving existing consultation and diagnostic methods.
Meddiction’s objective is to objectively diagnose various addictive diseases caused by alcohol, nicotine, drugs, gambling and internet usage and to develop and commercialize a virtual reality (VR) treatment solution using advanced display technology.
- Employees of Meddiction -
Meddiction follows rigorous clinical procedures for delivering products with stability and effectiveness.
Together with the leading psychiatric hospitals in Korea (large hospitals), we develop unique healthtech solutions based on product clinical trials in the following areas.
We develop products according to the characteristics of each customer group, and ensure that our products meet customer needs and requirements. Through continuous development, we will increase the value of Meddiction for the benefit of our customers.
Building B 603, 131, Gasan digital 1-ro, Geumcheon-gu, Seoul, Republic of Korea